Uplizna 100 mg concentrate for solution for infusion
20240202
Phase 2 small_molecule active
Quick answer
Uplizna 100 mg concentrate for solution for infusion for Immunoglobulin G4 related Disease (IgG4-RD) is a Phase 2 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Immunoglobulin G4 related Disease (IgG4-RD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active